Home > Newsletters > FDAnews Drug Daily Bulletin > Industry Collaboration Needed to Address ‘Crisis State’ of Shortages
FDAnews Drug Daily Bulletin
June 13, 2012 | Vol. 9 No. 116
Industry Collaboration Needed to Address ‘Crisis State’ of Shortages
Drug shortages, poor product quality, poor corrective actions and other “manufacturing breakdowns” have conspired to create a crisis state that demands not only strong regulatory enforcement, but also active collaboration among drugmakers, FDA officials say. “The shortages are the straw that broke the camel’s back for industry and regulators,” Steve Lynn, acting director of CDER’s Office of Manufacturing and Product Quality, said Tuesday.
Washington Drug Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.